SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-229431
Filing Date
2021-07-29
Accepted
2021-07-29 17:30:48
Documents
4
Effectiveness Date
2021-07-29

Document Format Files

Seq Description Document Type Size
1 S-8 d108620ds8.htm S-8 71739
2 EX-5.1 d108620dex51.htm EX-5.1 4791
3 EX-23.1 d108620dex231.htm EX-23.1 2997
4 GRAPHIC g108620g80s58.jpg GRAPHIC 3647
  Complete submission text file 0001193125-21-229431.txt   85823
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258279 | Film No.: 211128811
SIC: 2836 Biological Products, (No Diagnostic Substances)